A virus that infects your brain, makes you want to bite things and is almost always fatal after symptoms appear probably sounds like something from a zombie movie. However, this has been the modus operandi of rabies at least since 2300 BC, when it was described in the Eshuma Code of Babylon. The word’s Sanskrit etymology — rabhas, meaning “to do violence” — dates back even further, to 3000 BC.
In principle, no human in this day and age should die from rabies, and yet, according to a study last year, the virus kills 59,000 people annually. That is 160 people every day and the actual number might be far higher if we could count unreported or untreated cases. Most of these deaths occur in Asia and Africa, with India alone accounting for one-third of the world’s total mortality from rabies.
That total is not as high as the death toll from tuberculosis, HIV/AIDS and malaria; but, unlike those diseases, every mammal appears to be susceptible to rabies. Dogs, the predominant host in most regions, can become infected from any rabid wild animal and then infect humans. Dogs showing symptoms might bite a human, but they can also transmit the virus simply by licking if their saliva comes into contact with a scratch, damaged skin or mucosa.
The rabies virus hijacks the nervous system and actually manipulates neural processes to make its host move faster. Infected humans will eventually hallucinate, become aggressive and even fear water in the advanced stages of the disease.
Once these symptoms appear, rabies has no known cure and death is almost certain. Fortunately, unlike most vaccine-preventable diseases, rabies allows for post-exposure inoculation, because the time of infection is generally known by the victim — especially if they were bitten — and the disease’s incubation period is relatively long, ranging from days to years, but averaging three to eight weeks. Whether administered before or after exposure, the vaccine is the same, but the immunization schedule and the dosage differ between the two scenarios.
French scientist Louis Pasteur formulated the first rabies vaccine in 1885, by injecting the virus into rabbits, waiting for it to kill them and then drying the infected nerve tissues to weaken the virus to the point that it could be safely administered. Then he successfully tested it on a nine-year-old boy who had been bitten by a rabid dog.
In today’s world, Pasteur would be thrown in jail for practicing as an unlicensed physician and not following proper clinical-practice standards, but we can all be thankful for his discovery.
Today, rabies vaccines are grown in a lab using cell cultures. The virus is then rendered inactive, purified and administered by injection into the arm. The WHO recommends pre-exposure vaccinations for anyone whose occupation or residence implies continual, frequent or increased risk of encountering rabies. This applies to everyone in rabies-endemic countries; unfortunately, not everyone in these countries gets vaccinated.
The rabies vaccine is on the WHO List of Essential Medicines and has an average wholesale price of US$11 per dose in the developing world, and as much as US$250 per dose in the US. Of course, because the alternative to post-exposure vaccination is death, the treatment is extremely cost-effective however one looks at it.
Smallpox, which is believed to have emerged even before rabies, has now been eradicated, and programs are currently under way to put an end to polio, Guinea worm disease and other infectious ailments. So why is rabies still prevalent?
One reason is that the virus is almost always transmitted by animals, rather than by other humans. To address this, we should be investing in pet vaccinations, reducing wild and stray-animal populations, and enforcing strict quarantines on animals crossing national borders.
In developed countries, preventing rabies largely requires controlling and immunizing wildlife populations, which has proved effective in Switzerland and Germany. In Latin American countries, where bat rabies is a threat, bovine vaccines have been used, as have anticoagulants, to kill bats that feed off the blood of the treated cattle.
Ultimately, the world’s poorest regions still bear most of the rabies burden. Dogs are not widely vaccinated, as they are in developed countries; and even when they are, their populations turn over very rapidly. Within a year of a large-scale vaccination effort, a new population of unvaccinated dogs will be roaming the streets and increasing the chances of an outbreak.
Meanwhile, developing countries’ healthcare systems are already grappling with tuberculosis, HIV/AIDS and malaria; and post-exposure prophylaxis supplies are limited.
Barring real progress on these challenges, one of the world’s oldest known viruses will continue to afflict humans and animals alike.
Melvin Sanicas, a public health physician and vaccinologist, is regional medical expert at Sanofi Pasteur, Asia, Japan and the Pacific.
Copyright: Project Syndicate
Recently, China launched another diplomatic offensive against Taiwan, improperly linking its “one China principle” with UN General Assembly Resolution 2758 to constrain Taiwan’s diplomatic space. After Taiwan’s presidential election on Jan. 13, China persuaded Nauru to sever diplomatic ties with Taiwan. Nauru cited Resolution 2758 in its declaration of the diplomatic break. Subsequently, during the WHO Executive Board meeting that month, Beijing rallied countries including Venezuela, Zimbabwe, Belarus, Egypt, Nicaragua, Sri Lanka, Laos, Russia, Syria and Pakistan to reiterate the “one China principle” in their statements, and assert that “Resolution 2758 has settled the status of Taiwan” to hinder Taiwan’s
The past few months have seen tremendous strides in India’s journey to develop a vibrant semiconductor and electronics ecosystem. The nation’s established prowess in information technology (IT) has earned it much-needed revenue and prestige across the globe. Now, through the convergence of engineering talent, supportive government policies, an expanding market and technologically adaptive entrepreneurship, India is striving to become part of global electronics and semiconductor supply chains. Indian Prime Minister Narendra Modi’s Vision of “Make in India” and “Design in India” has been the guiding force behind the government’s incentive schemes that span skilling, design, fabrication, assembly, testing and packaging, and
Singaporean Prime Minister Lee Hsien Loong’s (李顯龍) decision to step down after 19 years and hand power to his deputy, Lawrence Wong (黃循財), on May 15 was expected — though, perhaps, not so soon. Most political analysts had been eyeing an end-of-year handover, to ensure more time for Wong to study and shadow the role, ahead of general elections that must be called by November next year. Wong — who is currently both deputy prime minister and minister of finance — would need a combination of fresh ideas, wisdom and experience as he writes the nation’s next chapter. The world that
As former president Ma Ying-jeou (馬英九) wrapped up his visit to the People’s Republic of China, he received his share of attention. Certainly, the trip must be seen within the full context of Ma’s life, that is, his eight-year presidency, the Sunflower movement and his failed Economic Cooperation Framework Agreement, as well as his eight years as Taipei mayor with its posturing, accusations of money laundering, and ups and downs. Through all that, basic questions stand out: “What drives Ma? What is his end game?” Having observed and commented on Ma for decades, it is all ironically reminiscent of former US president Harry